NCT02247375View on ClinicalTrials.gov

Pharmacokinetics, Safety and Efficacy of BIIL 284 BS in Patients With Rheumatoid Arthritis (RA)

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

January 31, 2000

Primary Completion Date

May 31, 2000

Conditions
Arthritis, Rheumatoid
Interventions
DRUG

Low dose of BIIL 284 BS tablets

DRUG

High dose of BIIL 284 BS tablets

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY